Obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors.
Parekh
Niyati
N
Department of Nutrition, Food Studies, and Public Health, New York University, New York, USA.
Okada
Tomoko
T
Lu-Yao
Grace L
GL
D054392:Adipokines / Q000097:blood / Q000378:metabolism; D052242:Adiponectin / Q000097:blood / Q000378:metabolism; D016207:Cytokines / Q000097:blood / Q000378:metabolism; D004046:Dietetics / Q000379:methods / Q000458:organization & administration*; D018450:Disease Progression; D015438:Health Behavior; D006801:Humans; D007249:Inflammation / Q000453:epidemiology* / Q000209:etiology / Q000378:metabolism / Q000401:mortality; D007333:Insulin Resistance; D020738:Leptin / Q000097:blood / Q000378:metabolism; D008019:Life Style; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology / Q000378:metabolism / Q000401:mortality; D009765:Obesity / Q000150:complications* / Q000453:epidemiology / Q000378:metabolism / Q000401:mortality; D015995:Prevalence; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate; D014481:United States / Q000453:epidemiology
D054392:Adipokines; D052242:Adiponectin; D016207:Cytokines; D020738:Leptin